Anti-cancer effect of bio-reductive drug β-lapachon is enhanced by activating NQO1 with heat shock

References

• Blackburn RV, Galofore SS, Corry PM, Lee YJ. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res 1998; 58: 1358–1362
   PubMed Web of Science ®Google Scholar
• Borrellli MJ, Schoenherr DM, Wong A, Bernock LJ, Corry PM. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res 2001; 61: 1113–1121
   PubMed Web of Science ®Google Scholar
• Huang Q, Hu JK, Lohr F, Zhang L, Brown R, Lanzen J, Little JB, Dewhirst MW, Li CY. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 2000; 60: 3435–3439
   PubMed Web of Science ®Google Scholar
• Li GC, He F, Shao X, Urano M, Shen L, Kim D, Borrelli M, Leiberl SA, Gutin PH, Ling CC. Adenovirum-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res 2003; 63: 3268–3274
   PubMed Web of Science ®Google Scholar
• Park HJ, Ahn KJ, Ahn SD, Choi E, Lee SW, Williams B, Kim EJ, Griffin R, Bey EA, Bornmann WG, et al. Susceptibility of cancer cells to β-lapachone is enhanced by ionizing radiation. Int J Radiation Oncol Biol Phys 2005; 61: 212–219
   PubMed Web of Science ®Google Scholar
• Suzuki M, Amano M, Choi J, Park HJ, Williams B, Ono K, Song CW. Synergistic effects of radiation and B-lapachone in DU-145 human prostate cancer cells in vitro. Radiation Res 2006; 165: 525–531
   PubMed Web of Science ®Google Scholar
• Choi EK, Terai K, Ji IM, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, et al. Upregulation of NAD(P)H: quinone oxidoreductase (NQO1) by radiation potentiates the effect of bioreductive β-lapachone against cancer cells. Neoplasia 2007; 9: 634–642
   PubMed Web of Science ®Google Scholar
• Park HJ, Choi EK, Choi J, Ahn K, Kim EJ, Ji IM, Kook YH, Ahn S, Williams B, Griffin RJ, et al. Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of β-lapachone. Clin Cancer Res 2005; 11: 8866–8871
   PubMed Web of Science ®Google Scholar
• Gutierrez PL. The role of NAD(P)H oxidoreductase (DT-diaphorase) in the bioactivation of quinine-containing antitumor agents: A review. Free Radic Biol Med 2000; 29: 263–275
   PubMed Web of Science ®Google Scholar
• Pan SS, Forrest GL, Akman SA, Hu LT. NAD(P)H: quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT116 cells. Cancer Res 1995; 55: 330–335
   PubMed Web of Science ®Google Scholar
• Begleiter A, Fourie J. Induction of NQO1 in cancer cells. Methods in Enzymol 2004; 382: 321–351
   Web of Science ®Google Scholar
• Rauth AM, Goldberg Z, Mirsa V. DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis. Oncol Res 1997; 9: 339–349
   PubMed Web of Science ®Google Scholar
• Ross D, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods in Enzymol 2004; 382: 115–144
   PubMed Web of Science ®Google Scholar
• Siegel D, Beall H, Senekowitach C, Kasai M, Arai H, Gibson NW, Ross D. Bioreductive activation of mitomycin C by DT-diaphorease. Biol Chem 1992; 31: 7879–7885
   Google Scholar
• Loadman PM, Bibby MC, Phillips RM. Pharmacological approach towards used on the clinically inactive agent EO9. The development of indolequinone bioreductive drugs. Br J Pharmacol 2002; 137: 701–709
   PubMed Web of Science ®Google Scholar
• Winski SL, Swann E, Hargreaves RH, Dehn DL, Butler J, Moody CJ, Ross D. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 2001; 61: 1509–1516
   PubMed Web of Science ®Google Scholar
• Fitzsimmons SA, Workman P, Rever M, Paull K, Camalier R, Lewis AD. Reductase enzyme expression across the National Cancer Institute tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst 1996; 88: 259–269
   PubMed Web of Science ®Google Scholar
• Begleiter A. Clinical applications of quinone-containing alkylating agents. Front Bioscience 2000; 5: E153–171
   PubMed Web of Science ®Google Scholar
• Guo W, Reigan P, Siegel D, Zirrolli J, Gustafson D, Ross D. Formation of 17-allyaminodemethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition. Cancer Res 2005; 65: 10006–10015
   PubMed Web of Science ®Google Scholar
• Sharp SY, Kelland LR, Valenti MR, Brunton MA, Hobbs S, Workman P. Establishment of an isogenic human colon tumor model for NQO1 gene expression: Application to investigate the role of DT-diaphorase in bioredcutive drug activation in vitro and in vivo. Mol Pharmacol 2000; 58: 1146–1155
   PubMed Web of Science ®Google Scholar
• Marin A, Lopez de Cerain A, Hamilton E, Lewis AD, Martinez-Penuela JM, Idoate MA, Bello J. DT-diaphorase and cytochrome B5 reductase in human lung and breast tumors. Br J Cancer 1997; 76: 923–929
   PubMed Web of Science ®Google Scholar
• Siegel D, Franklin WA, Ross D. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors. Clin Cancer Res 1998; 4: 2065–2070
   PubMed Web of Science ®Google Scholar
• Belinsky M, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 1993; 12: 103–117
   PubMed Web of Science ®Google Scholar
• Cresteil T, Jaiswal AK. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol 1991; 42: 1021–1027
   PubMed Web of Science ®Google Scholar
• Beall HD, Murphy AM, Siegel D, Hargreaves RH, Butler J, Ross D. NAD(P)H:quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: Quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol Pharmacol 1995; 48: 499–504
   PubMed Web of Science ®Google Scholar
• Planchon SM, Pink JJ, Tagliarino C, BornmannWG, Varnes ME, Boothman DA. β-lapachone-induced apoptosis in human prostate cancer cells: Involvement of Nqo/xip3. Exp Cell Res 2001; 267: 95–106
   PubMed Web of Science ®Google Scholar
• Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, Boothman DA. NAD(P)H: quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J Biol Chem 2000; 275: 5416–5424
   PubMed Web of Science ®Google Scholar
• Pink JJ, Wuerzberger-Davis S, Tagliarino C, Planchon SM, Yang X, Froelich CJ, Boothman DA. Activation of cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone mediated apoptosis. Exp Cell Res 2000; 255: 144–155
   PubMed Web of Science ®Google Scholar
• Tagliarino C, Pink JJ, Dubyak GR, Nieminen AL, Boothman DA. Calcium is a key signaling molecule in beta-lapachone mediated cell death. J Biol Chem 2001; 276: 19150–19159
   PubMed Web of Science ®Google Scholar
• Li Y, Sun X, LaMont JT, Pardee AB, Li CJ. Selective killing of cancer cells by β-lapachone: Direct checkpoint activation as a strategy against cancer. Proc Natl Acad Sci USA 2003; 100: 2674–2678
   PubMed Web of Science ®Google Scholar
• Pardee AB, Li YZ, Li C. Cancer therapy with β-lapachone. Current Cancer Drug Targets 2002; 2: 227–242
   PubMed Web of Science ®Google Scholar
• Li CJ, Li YZ, Pinto AV, Pardee AB. Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: Xombining drugs imposes different artificial checkpoints. Proc Natl Acad Sci USA 1999; 96: 13369–13374
   PubMed Web of Science ®Google Scholar
• Li CJ, Wang C, Pardee AB. Induction of apoptosis by beta-lapachon in human prostate cancer cells. Cancer Res 1995; 55: 3712–3715
   PubMed Web of Science ®Google Scholar
• Huang L, Pardee AB. β-Lapachone induces cell cycle arrest and apoptosis in human colon cancer. Mol Med 1999; 5: 711–720
   PubMed Web of Science ®Google Scholar
• Bentle MS, Reinicke KE, Dong Y, Bey EA, Bootheman DA. Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, B-lapachone. Cancer Res 2007; 67: 6936–6945
   PubMed Web of Science ®Google Scholar
• Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang CR, Girard L, Minna JD, Bornmann WG, Gao J, Boothman DA. An NQO1- and PARP1-1 mediated cell death pathway induced in non-small cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci USA 2007; 1004: 11832–11837
   Web of Science ®Google Scholar
• Boothman DA, Trask DK, Pardee AB. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase. Cancer Res 1989; 49: 605–612
   PubMed Web of Science ®Google Scholar
• Jaiswal AK. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic Biol Med 2000; 29: 254–262
   PubMed Web of Science ®Google Scholar
• Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 2005; 280: 16891–16900
   PubMed Web of Science ®Google Scholar
• Chen S, Knox R, Lewis AD, Friedlos F, Workman P, Deng PS, Fung M, Ebenstein D, We K, Tsai TM. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: Study involving mouse, rat, human, and mouse-rat chimeric enzyme. Mol Pharmacol 1995; 47: 934–939
   PubMed Web of Science ®Google Scholar
• Chen S, Knox R, Wu K, Deng PS, Zhou D, Bianchet MA, Amzel LM. Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse. J Bio Chem 1997; 272: 1437–1439
   PubMed Web of Science ®Google Scholar
• Danson S, Ward TH, Butler J, Ranson M. DT-diaphorase: A target for new anticancer drugs. Cancer Treat Rev 2004; 30: 437–449
   PubMed Web of Science ®Google Scholar
• Winski SL, Swann E, Hargreaves RH, Dehn DL, Butler J, Moody CJ, Ross D. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 2002; 61: 1509–1516
   Web of Science ®Google Scholar